Novavax Completes Enrolling 30,000 People in U.S. Trial of COVID-19 Vaccine

The company said last month its vaccine was 89.3% effective in preventing COVID-19 in a trial conducted in the United Kingdom, and was nearly as effective against the more highly contagious variant ...